Aurora Cannabis Inc.
ACB.TOTSXHealthcare● Active
$4.77
+$0.07(+1.49%)
Market Cap$270503838
P/E Ratio—
52W High$9.33
52W Low$4.285
Aurora Cannabis Inc. (ACB.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ACB.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 4, 2026EPS Actual
$0.03
Est. $0.13 · -77.5%
Revenue
$0.09B
Est. $0.09B · +2.0%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 4, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
ACB.TO reports quarterly as a TSX-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 11, 2026 | -$0.06 | — | — | — | $0.08B | — |
| ▼ Q1 FY2026 | Feb 4, 2026 | $0.13 | $0.03 | -77.5% | $0.09B | $0.09B | +2.0% |
| ▲ Q4 FY2025 | Nov 4, 2025 | $0.02 | $0.57 | +3534.0% | $0.09B | $0.09B | +2.0% |
| ▼ Q3 FY2025 | Aug 5, 2025 | $0.16 | -$0.27 | -266.2% | $0.10B | $0.09B | +4.6% |
| ▼ Q2 FY2025 | Jun 18, 2025 | $0.13 | -$0.44 | -447.6% | $0.09B | $0.09B | +1.9% |
| ▲ Q1 FY2025 | Feb 6, 2025 | -$0.05 | $0.58 | +1260.0% | $0.09B | $0.09B | -0.7% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -$0.10 | -$0.22 | -120.0% | $0.08B | $0.07B | +15.8% |
| ▲ Q3 FY2024 | Aug 7, 2024 | -$0.19 | $0.13 | +168.4% | $0.08B | $0.08B | +8.1% |
Q2 FY2026
Jun 11, 2026
EPS Actual
—
EPS Est.
-$0.06
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 4, 2026Miss
EPS Actual
$0.03
EPS Est.
$0.13
EPS Surpr.
-77.5%
Revenue
$0.09B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
$0.57
EPS Est.
$0.02
EPS Surpr.
+3534.0%
Revenue
$0.09B
Q3 FY2025
Aug 5, 2025Miss
EPS Actual
-$0.27
EPS Est.
$0.16
EPS Surpr.
-266.2%
Revenue
$0.10B
Q2 FY2025
Jun 18, 2025Miss
EPS Actual
-$0.44
EPS Est.
$0.13
EPS Surpr.
-447.6%
Revenue
$0.09B
Q1 FY2025
Feb 6, 2025Beat
EPS Actual
$0.58
EPS Est.
-$0.05
EPS Surpr.
+1260.0%
Revenue
$0.09B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
-$0.22
EPS Est.
-$0.10
EPS Surpr.
-120.0%
Revenue
$0.08B
Q3 FY2024
Aug 7, 2024Beat
EPS Actual
$0.13
EPS Est.
-$0.19
EPS Surpr.
+168.4%
Revenue
$0.08B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2027 | $0.01 | $0.01 | $0.01 | 1 |
| Q4 FY2026 | $0.08 | $0.09 | $0.10 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 2 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 3 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 3 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Feb 4, 2026 | -77.5% | $5.55 | $5.11 | -7.93% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +3534.0% | $6.86 | $6.42 | -6.41% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -266.2% | $6.17 | $6.34 | +2.76% |
| ▼ Q2 FY2025 | Jun 18, 2025 | -447.6% | $8.02 | $6.40 | -20.20% |
| ▲ Q1 FY2025 | Feb 6, 2025 | +1260.0% | $7.65 | $8.96 | +17.12% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -120.0% | $8.46 | $7.11 | -15.96% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +168.4% | $8.11 | $8.59 | +5.92% |
| ▼ Q2 FY2024 | Jun 20, 2024 | -13.0% | $7.73 | $7.54 | -2.46% |
Q1 FY2026-7.93%
Report Date
Feb 4, 2026
EPS Beat/Miss
-77.5%
Price Before
$5.55
Price After
$5.11
Q4 FY2025-6.41%
Report Date
Nov 4, 2025
EPS Beat/Miss
+3534.0%
Price Before
$6.86
Price After
$6.42
Q3 FY2025+2.76%
Report Date
Aug 5, 2025
EPS Beat/Miss
-266.2%
Price Before
$6.17
Price After
$6.34
Q2 FY2025-20.20%
Report Date
Jun 18, 2025
EPS Beat/Miss
-447.6%
Price Before
$8.02
Price After
$6.40
Q1 FY2025+17.12%
Report Date
Feb 6, 2025
EPS Beat/Miss
+1260.0%
Price Before
$7.65
Price After
$8.96
Q4 FY2024-15.96%
Report Date
Nov 6, 2024
EPS Beat/Miss
-120.0%
Price Before
$8.46
Price After
$7.11
Q3 FY2024+5.92%
Report Date
Aug 7, 2024
EPS Beat/Miss
+168.4%
Price Before
$8.11
Price After
$8.59
Q2 FY2024-2.46%
Report Date
Jun 20, 2024
EPS Beat/Miss
-13.0%
Price Before
$7.73
Price After
$7.54
Avg Beat Reaction+5.54%
Avg Miss Reaction-8.76%
Beat Rate3 / 8 quarters
Largest Move-20.20% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ACB.TO ends December
Aurora Cannabis Inc. (ACB.TO) most recently reported earnings on February 4, 2026 for Q1 FY2026, posting EPS of $0.03 — missing the analyst consensus of $0.13 by -77.5%. The next ACB.TO earnings date is expected around September 1, 2026.
Each quarter, investors track ACB.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ACB.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ACB.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ACB.TO earnings · 5 questionsAurora Cannabis Inc.'s next earnings report is expected around September 1, 2026. ACB.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ACB.TO historically reports after market close (AMC).
ACB.TO earnings datewhen is ACB.TO earningsACB.TO next earnings datewhen does ACB.TO report earningsACB.TO earnings calendar
▸ Source: FMP · Aurora Cannabis Inc. SEC filings · US GAAP · Aurora Cannabis Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026